Refine by
Miradx Immune Development Services
1 services found
Manufactured by:MiraDx based inLos Angeles, CALIFORNIA (USA)
Patients with any type of cancer who are being considered for anti-PD1 or anti-PDL1 therapy are eligible for testing. This test predicts the risk of developing immune related adverse events in response to anti-PD1 or anti-PDL1 treatment. ...